Mr. Brian Bapty reports

HELIUS OPENS NEW SITE FOR PIVOTAL MILD TO MODERATE TRAUMATIC BRAIN INJURY TRIAL AT HEALTHTECH CONNEX IN SURREY, BRITISH COLUMBIA

HealthTech Connex Inc. (HTC) in Surrey, B.C., will be the fourth site for Helius Medical Technologies Inc.'s continuing pivotal trial investigating PoNS therapy for the treatment of subjects with balance disorder resulting from mild to moderate traumatic brain injury (TBI). Clinical trial sites in the United States and Canada include the Montreal Neurofeedback Center, Oregon Health, and Science University and Orlando Regional Medical Center.

"We are thrilled to be expanding our clinical presence and look forward to working with the dedicated team of professionals HTC has assembled to facilitate this study," said Helius chief executive officer, Phil Deschamps. "The shared vision to improve care for those suffering from brain injuries connected Helius with HealthTech Connex. Their expertise in neurotechnology, brain imaging and brain trauma, as well as their broad network in the TBI community provides a sound foundation for adding this fourth PoNS clinical trial site."

"HealthTech Connex is excited to be a service provider for Helius, with our new facilities at the health and technology district in Surrey," said Dr. Ryan D'Arcy, HTC president and chief scientific officer. "Furthering the understanding of neuroplasticity and pioneering treatments for brain injury are our common goals as we investigate potential solutions to this considerable unmet medical need."

To learn more about the clinical trial, the clinical trial sites and recruitment opportunities please visit the company's website.

About PoNS therapy

The Portable Neuromodulation Stimulator (PoNS) is an investigational non-invasive device designed to deliver neurostimulation through the tongue. PoNS therapy combines the use of the device with physical therapy and is currently being evaluated in a multicentre clinical trial for the treatment of balance disorder for subjects with mild to moderate traumatic brain injury.

We seek Safe Harbor.